ClinConnect ClinConnect Logo
Search / Trial NCT07137520

The Impact of Various Exercise Intensities on Energy Expenditure Metabolism

Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · Aug 11, 2025

Trial Information

Current as of September 04, 2025

Not yet recruiting

Keywords

Metabolic Response Energy Expenditure Physical Fitness

ClinConnect Summary

This clinical trial is studying how different levels of physical activity affect the body’s energy use in adults. The main question is whether exercising more can keep increasing the total amount of energy the body uses in a day. To find out, participants will wear a device that tracks their daily physical activity, have their total energy use measured through a special water test, and spend time in a controlled room where their resting energy use and how their body uses energy after eating will be checked.

Adults of all genders with a body mass index (BMI) of 18.5 or higher may be eligible to join, as long as they don’t have certain health conditions like recent major surgery, serious heart or metabolic diseases (like diabetes or high blood pressure), exercise injuries, infections, mental health disorders, or recent attempts to lose or gain weight. Pregnant or breastfeeding individuals and those with metal implants or autism are also excluded. If you join, you can expect to be closely monitored through these tests to better understand how your body uses energy with different amounts of physical activity. This study has not started recruiting yet, but it aims to help us learn how exercise affects energy use, which could be important for health and fitness recommendations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • BMI ≥ 18.5 kg/m2
  • Exclusion Criteria:
  • Individuals who have undergone major surgery in the past 6 months (excluding tooth extraction);
  • Individuals with severe metabolic and cardiovascular diseases such as diabetes, hypoglycemia, and hypertension;
  • Individuals with exercise-related injuries, including joint diseases and fractures;
  • Individuals diagnosed with infectious diseases such as HIV, tuberculosis, malaria, etc.;
  • Individuals with mental and neurological disorders including anorexia nervosa;
  • Individuals who have attempted weight loss or gain through various methods in the past three months;
  • Individuals in preconception, pregnancy, and lactation periods;
  • Individuals with autism and those with metal implants in their bodies.

About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences

The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.

Locations

Shenzhen, Guang Dong, China

Patients applied

0 patients applied

Trial Officials

John R Speakman, PhD

Principal Investigator

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported